Antimetabolites and cytotoxic drugs

Dermatologic Clinics

Volumn 19, Issue 1, 2001, Pages 105-118

  Silvis, Nancy G ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TIOGUANINE;

AUTOIMMUNE DISEASE; BONE MARROW SUPPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG ABSORPTION; DRUG MONITORING; DRUG STRUCTURE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; REVIEW;

EID: 0035168431     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(05)70233-3     Document Type: Article

References (73)

1. Azathioprine in the treatment of pemphigus vulgaris
2. Cyclophosphamide (Cytoxan) A review on relevant pharmacology and clinical uses
3. A clinical approach to the use of methotrexate for sarcoidosis
4. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus
5. Azathioprine-induced shock
6. Thioguanine in the treatment of certain autoimmune, immunologic and related diseases
7. Immunosuppressive agents in dermatology
8. Reversal of erythema multiforme major with cyclophosphamide and prednisone
9. Mycophenolate is effective in the treatment of pemphigus vulgaris
10. Mycophenolic acid for psoriasis
11. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis
12. Pulse intravenous cyclosphosphamide therapy in pemphigus
13. Cyclophosphamide in the treatment of toxic epidermal necrolysis
14. Mycophenolate mofetil for the treatment of systemic lupus erythematosus
15. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome
16. Successful treatment of erythrodermic psoriasis with mycophenolate mofetil
17. Hepatic venoocclusive disease caused by 6-thioguanine
18. A new therapeutic option in the treatment of blistering autoimmune diseases
19. Treatment of pemphigus vulgarus and bullous pemphigoid with mycophenolate mofetil monotherapy
20. Therapeutic suppression of tissue reactivity: Effect of aminopterin in rheumatoid arthritis and psoriasis
21. Psoriasis vulgaris treated successfully with mycophenolate mofetil
22. Efficacy of cyclophosphamide in toxic epidermal necrolysis
23. Wegener's granulomatosis: An analysis of 158 patients
24. Kasabach-Merritt syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D
25. Thrombocytopenia after a single test dose of methotrexate
26. Treatment of psoriasis with oral mycophenolic acid
27. Azathioprine-induced shock in dermatology patients
28. 6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease
29. Actinic reticuloid in a black man: Successful therapy with azathioprine
30. Teratogenic effects of first-trimester cyclophosphamide therapy
31. Reversible hepatic veno-occlusive disease and 6-thioguanine
32. Erosive and generalized lichen planus responsive to azathioprine
33. Retrospective review of the use of azathioprine in severe atopic dermatitis
34. Mycophenolate mofetil
35. Cytotoxic agents for use in dermatology
36. Diagnosis and treatment of systemic lupus erythematosus
37. Thioguanine treatment in psoriasis
38. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis
39. Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis
40. Successful treatment of severe polymorphous light eruption with azathioprine
41. The role of mycophenolate mofetil in the management of pemphigus
42. Mycophenolate in psoralen-UV-A desensitization therapy for chronic actinic dermatitis
43. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: Report of a case and review of this new therapy for severe autoimmune disease
44. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil
45. Successful therapy for bullous pemphigoid with mycophenolate mofetil
46. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrennosum
47. Mycophenolate mofetil in autoimmune and inflammatory skin disorders
48. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide
49. Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide
50. Dyshidrotic eczema treated with mycophenolate mofetil
51. Psoriasis and bullous pemphigoid treated with azathioprine
52. Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis
53. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis
54. Intravenous cyclophosphamide pulses in pyoderma gangdrenosum
55. Methotrexate and liver biopsies: Is it really necessary?
56. Methotrexate in psoriasis: Revised guidelines
57. Methotrexate in psoriasis: Consensus conference
58. 6-Thioguanine as a cause of toxic veno-occlusive disease of the liver
59. The use of folates concomitantly with low-dose pulse methotrexate
60. Pancytopenia following low-dose oral methotrexate therapy for psoriasis
61. Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses
62. Pulse dosing of thioguanine in recalcitrant psoriasis
63. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients
64. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis
65. Azathioprine in dermatology: A survey of current practice in the U.K.
66. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders
67. Pulse intravenous cyclophosphamide for treatment of autoimmune blistering disease: Is there an advantage over oral routes?
68. Hypocomplementaemic urticarial vasculitis: Successful treatment with cyclophosphamide-dexamethasone pulse therapy
69. Azathioprine in dermatology
70. 6-Thioguanine treatment of psoriasis: Experience in 81 patients
71. Treatment of psoriasis with 6-thioguanine
72. Treatment of dermatomyositis with methotrexate
73. Methotrexate osteopathy in long-term low-dose methotrexate treatment for psoriasis and rheumatoid arthritis